Cochrane · systematic review · CD009045
Bendamustine for patients with indolent B cell lymphoid malignancies including chronic lymphocytic leukaemia
Vidal, L, Gafter‐Gvili, A, Gurion, R, et al. · Cochrane Database of Systematic Reviews · 2012 · Cochrane Library
HaematologyAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
2
current version
GRADE rated
2
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 2 · 100%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Questions and results
Comparison
Population: patients with indolent B cell lymphoid malignancy
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Overall survival Median | no estimate extracted | 2 studies · 481 participants | Moderate |
All‐cause mortality Median | no estimate extracted | 4 studies · 1202 participants | Moderate |